Co
Key Metrics
Market Snapshot
About
Co-Diagnostics, Inc. (CODX) is a molecular diagnostics company headquartered in Salt Lake City, Utah. It is known for developing and manufacturing reagents and tests used in polymerase chain reaction (PCR) technology to detect infectious diseases.
The company primarily makes money by selling reagents, which are chemical substances used to perform diagnostic tests that analyze nucleic acids like DNA and RNA. Its flagship offering is the Co-Dx PCR platform, designed to enable PCR testing in point-of-care locations such as clinics or even in at-home settings. The company's tests target a range of infectious diseases, including COVID-19, influenza, tuberculosis, hepatitis B and C, and various mosquito-borne viruses like dengue and Zika.
Beyond human health, Co-Diagnostics applies its technology to other markets. It provides multiplexed tests to identify diseases in mosquitoes and develops molecular tools for detecting traits within plant and animal genomes. Founded in 2013, the company operates both in the United States and internationally, focusing on making advanced molecular diagnostics more accessible outside of traditional laboratory environments.